2019
A multidisciplinary approach to the clinical management of Prader–Willi syndrome
Duis J, van Wattum P, Scheimann A, Salehi P, Brokamp E, Fairbrother L, Childers A, Shelton A, Bingham N, Shoemaker A, Miller J. A multidisciplinary approach to the clinical management of Prader–Willi syndrome. Molecular Genetics & Genomic Medicine 2019, 7: e514. PMID: 30697974, PMCID: PMC6418440, DOI: 10.1002/mgg3.514.Peer-Reviewed Original ResearchConceptsPrader-Willi syndromeMultidisciplinary clinicQuality family-centered careAppropriate clinical outcome measuresClinical outcome measuresMultidisciplinary approachFamily-centered careUnmet medical needPatient-centered careComplex neuroendocrine disorderCenters of excellenceCaregiver burdenClinical managementCare teamDearth of evidenceMedical homeNeuroendocrine disordersOutcome measuresNew therapiesRare diseaseAcademic centersCare practicesCare expertsMedical needNatural history
2014
Brain Stimulation in Psychiatry
van Wattum P. Brain Stimulation in Psychiatry. The Journal Of Clinical Psychiatry 2014, 75: e94. DOI: 10.4088/jcp.13bk08891.Peer-Reviewed Original Research
2013
Polypharmacy Reduction in Youth in a Residential Treatment Center Leads to Positive Treatment Outcomes and Significant Cost Savings
van Wattum PJ, Fabius C, Roos C, Smith C, Johnson T. Polypharmacy Reduction in Youth in a Residential Treatment Center Leads to Positive Treatment Outcomes and Significant Cost Savings. Journal Of Child And Adolescent Psychopharmacology 2013, 23: 620-627. PMID: 24251644, DOI: 10.1089/cap.2013.0014.Peer-Reviewed Original ResearchConceptsMedication reductionTreatment centersResidential treatment centerTreatment outcomesLong-term treatment outcomesUse of antipsychoticsNumber of antipsychoticsPlace of dischargePositive treatment outcomesAdmission medicationsAntipsychotic combinationsPolypharmacy reductionPostdischarge dataDischarge medicationsMore medicationsAvailable followMonths postdischargeMood stabilizersPolypharmacy regimensMedicationsAdmissionYouth ages 11Mean numberHealthcare systemAntipsychoticsDr Joksovic and colleagues reply.
Joksovic P, Mellos N, van Wattum P, Chiles C. Dr Joksovic and colleagues reply. The Journal Of Clinical Psychiatry 2013, 74: 518-9. PMID: 23759456, DOI: 10.4088/jcp.12lr08288a.Peer-Reviewed Original Research
2011
Clinical Manual of Adolescent Substance Abuse Treatment
van Wattum P. Clinical Manual of Adolescent Substance Abuse Treatment. The Journal Of Clinical Psychiatry 2011, 72: 1700-1701. DOI: 10.4088/jcp.11bk07448.Peer-Reviewed Original Research
2010
Practical Child and Adolescent Psychiatry for Pediatrics and Primary Care
van Wattum P. Practical Child and Adolescent Psychiatry for Pediatrics and Primary Care. The Journal Of Clinical Psychiatry 2010, 71: 963. DOI: 10.4088/jcp.09bk05751whi.Peer-Reviewed Original Research
2009
Clinical Handbook of Psychotropic Drugs for Children and Adolescents
van Wattum P. Clinical Handbook of Psychotropic Drugs for Children and Adolescents. The Journal Of Clinical Psychiatry 2009, 70: 301. DOI: 10.4088/jcp.08bk04947.Peer-Reviewed Original Research
2007
Child and Adolescent Psychiatry
van Wattum P. Child and Adolescent Psychiatry. The Journal Of Clinical Psychiatry 2007, 68: 1312. DOI: 10.4088/jcp.v68n0822a.Peer-Reviewed Original ResearchTourette's Syndrome and Pharmacotherapy
van Wattum P, Leckman J. Tourette's Syndrome and Pharmacotherapy. 2007 DOI: 10.1002/9780470101001.hcn055.Peer-Reviewed Original Research
2006
STUTTERING IMPROVED WITH RISPERIDONE
van Wattum PJ. STUTTERING IMPROVED WITH RISPERIDONE. Journal Of The American Academy Of Child & Adolescent Psychiatry 2006, 45: 133. PMID: 16429082, DOI: 10.1097/01.chi.0000190465.55329.b0.Peer-Reviewed Original Research
2005
Clinical Handbook of Psychotropic Drugs for Children and Adolescents
van Wattum P. Clinical Handbook of Psychotropic Drugs for Children and Adolescents. The Journal Of Clinical Psychiatry 2005, 66: 1617. DOI: 10.4088/jcp.v66n1220a.Peer-Reviewed Original Research
2003
Pleural Fluid Eosinophilia With Combined Pharmacotherapy
Chiles C, van Wattum PJ. Pleural Fluid Eosinophilia With Combined Pharmacotherapy. Journal Of The Academy Of Consultation-Liaison Psychiatry 2003, 44: 436-437. PMID: 12954922, DOI: 10.1176/appi.psy.44.5.436.Peer-Reviewed Original Research
2001
VALPROIC ACID AND RISPERIDONE
van Wattum P. VALPROIC ACID AND RISPERIDONE. Journal Of The American Academy Of Child & Adolescent Psychiatry 2001, 40: 866-867. PMID: 11501681, DOI: 10.1097/00004583-200108000-00003.Peer-Reviewed Original ResearchRapid response to low dose citalopram in pathological crying
van Wattum P, Chiles C. Rapid response to low dose citalopram in pathological crying. General Hospital Psychiatry 2001, 23: 167-168. PMID: 11447987, DOI: 10.1016/s0163-8343(01)00133-5.Peer-Reviewed Original ResearchThermal Sensitivity in Tourette Syndrome: Preliminary Report
Scahill L, Lombroso P, Mack G, Van Wattum P, Zhang H, Vitale A, Leckman J. Thermal Sensitivity in Tourette Syndrome: Preliminary Report. Perceptual And Motor Skills 2001, 92: 419-432. PMID: 11361302, DOI: 10.2466/pms.2001.92.2.419.Peer-Reviewed Original ResearchConceptsTourette syndromeSubgroup of patientsAge of onsetAdult male subjectsCurrent ageTic symptomsDopaminergic pathwaysSex distributionCurrent severityMale subjectsMean differenceSyndromeControl periodPreliminary reportSweat rateAgeSymptomsSubjectsOverall courseDegrees COnsetPatientsIllnessSeverityCourse
2000
Patterns of response to acute naloxone infusion in Tourette's syndrome
van Wattum P, Chappell P, Zelterman D, Scahill L, Leckman J. Patterns of response to acute naloxone infusion in Tourette's syndrome. Movement Disorders 2000, 15: 1252-1254. PMID: 11104215, DOI: 10.1002/1531-8257(200011)15:6<1252::aid-mds1030>3.0.co;2-i.Peer-Reviewed Original ResearchConceptsTourette syndromeTic behaviorsOpioid antagonist naloxoneDose-related effectsDose-response effectExpression of TSRandomized dosesAntagonist naloxoneNaloxone infusionOpioid receptorsLow doseHigh doseEarlier pilot studyPattern of responseSyndromeNaloxoneTS subjectsPilot studySignificant decreaseSignificant increaseDoseDifferent dosagesOpposite effectSubjectsVideotaped recordings
1999
Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered.
van Wattum PJ, Anderson GM, Chappell PB, Goodman WK, Riddle MA, Leckman JF. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered. Biological Psychiatry 1999, 45: 1527-8. PMID: 10356639.Peer-Reviewed Original Research
Others
- van Wattum, PJ (2013) [Chapter] Tuberous Sclerosis Mistaken for Attention Deficit Hyperactivity Disorder. Casebook of Neuropsychiatry. Hurwitz, TA, Lee, WT, Eds. APPI.Peer-Reviewed Original Research
- Mao AR, Treadwell-Deering D, Brams MN, van Wattum PJ (2009) [Chapter]: Impact on Parents of Raising a Child with a Psychiatric Illness and/or Developmental Disability. In: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th Ed. Sadock BJ, Sadock VA, Ruiz P, Eds. Lippincot, Williams & Wilkins, Baltimore, MD: 3895-3903Peer-Reviewed Original Research
- van Wattum PJ, Leckman JF (2007) [Chapter]: Tourette’s Syndrome and Pharmacotherapy. In: Handbook of Contemporary Neuropharmacology. Sibley D, Hamin I, Kuhar M, Skolnick P, Eds. John Wiley & Sons, Inc. Hoboken, NJ: 263-90Peer-Reviewed Original Research